These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3683923)

  • 21. [Anti thyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer: residual or relapsing disease markers?].
    Quevedo I; Campino C; Rodríguez Portales JA; Arteaga E; López JM; Campusano C; González G; Fardella C; Slater J; Valdivia L; Poggi H; Foradori A; Velasco S
    Rev Med Chil; 2002 Feb; 130(2):167-72. PubMed ID: 11974529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal sarcoma (GIST)--a review of surgical management.
    Lehnert T
    Ann Chir Gynaecol; 1998; 87(4):297-305. PubMed ID: 9891770
    [No Abstract]   [Full Text] [Related]  

  • 23. Renin in Wilms' tumor: prorenin as an indicator.
    Elder JS
    J Urol; 1995 Jul; 154(1):325-6. PubMed ID: 7776451
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-up.
    Samiian L; Weaver M; Velanovich V
    Am Surg; 2004 Mar; 70(3):187-91; discussion 191-2. PubMed ID: 15055839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin.
    Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2004 Apr; 30(3):280-5. PubMed ID: 15028309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign positive margins after radical prostatectomy means a poor prognosis--con.
    Rubin MA; Montie JE
    Urology; 2005 Feb; 65(2):221-3. PubMed ID: 15708026
    [No Abstract]   [Full Text] [Related]  

  • 28. [Special problems of gastrointestinal soft tissue sarcomas].
    Lehnert T
    Chirurg; 1993 Jul; 64(7):535-43. PubMed ID: 8375203
    [No Abstract]   [Full Text] [Related]  

  • 29. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of PSA follow-up in recurrent prostate carcinoma after radical prostatovesiculectomy].
    Trinkler F; Hauri D
    Helv Chir Acta; 1994 Dec; 60(6):1081-5. PubMed ID: 7533147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
    Hanisch E; Hottenrott C; Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [After-care of colorectal carcinoma--value of tumor markers].
    Köhne CH; Benter T
    Internist (Berl); 1997 Apr; 38(4):363-5. PubMed ID: 9213578
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H; Pedersen KV
    Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
    Berney DM
    Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844
    [No Abstract]   [Full Text] [Related]  

  • 36. Defining recurrence after radiation for prostate cancer.
    Kuban DA; Thames HD; Shipley WU
    J Urol; 2005 Jun; 173(6):1871-8. PubMed ID: 15879766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
    Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF
    Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen, biomarker discovery, and trial design.
    Yeatman TJ
    Ann Surg Oncol; 2006 May; 13(5):600-1. PubMed ID: 16538403
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.